Roka BioScience, Inc. 4
4 · Roka BioScience, Inc. · Filed Sep 23, 2016
Insider Transaction Report
Form 4
Boesgaard Lars
Vice President, CFO
Transactions
- Purchase
Warrant (right to buy)
2016-09-21+35,714→ 35,714 totalExercise: $0.70From: 2016-09-21Exp: 2016-09-21→ Common stock, par value $0.001 per share (35,714 underlying) - Purchase
Series A Convertible Preferred Stock
2016-09-21+25→ 25 totalExercise: $0.70→ Common stock, par value $0.001 per share (35,714 underlying)
Footnotes (2)
- [F1]Pursuant to the terms of the Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock and the lock up agreement dated September 21, 2016, reporting person's Series A Convertible Preferred Stock, par value $0.001 per share (the "Series A Preferred Shares") automatically converts, upon receipt by the Company of shareholder approval, into shares of the Company's common stock, par value $0.001 (the "Common Shares") at a conversion price of $0.70 per share. The Series A Preferred Shares have no expiration date.
- [F2]The reporting person purchased 25 Series A Preferred Shares and five-year warrants to purchase 35,714 Common Shares at a purchase price of $1,000 per share pursuant to a private offering of the Company for a total of $25,000.